Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06415474

Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients admitted for polytrauma, severe neurological injury, post-operative monitoring or sepsis/septic shock present with significant inflammation, leading to immunoparalysis, which is responsible for infection, particularly prolonged infection. A study of their lymphocyte phenotype over time could help explore the phenomenon of immunoparalysis.

Conditions

Interventions

TypeNameDescription
PROCEDURELymphocyte Phenotyping ProcedureFor all patients, lymphocyte phenotyping will be performed on biological samples taken on D0, D7 and the day of discharge. In case of infection, phenotyping will also be performed on the day of infection diagnosis and on the day corresponding to half the duration of antibiotic therapy. For phenotyping, only 1.5 mL will be used. In case of infection, an additional 1mL will be collected (0.5mL on the day of inclusion diagnosis and 0.5 mL on the day corresponding to half the duration of antibiotic therapy). Blood is collected during sampling, which takes place several times a day as part of the standard management of these patients. It is important to note that phenotyping is not routinely performed as part of routine care. An additional tube is therefore taken specifically for this analysis, but this is done without the need for an additional puncture.

Timeline

Start date
2024-10-03
Primary completion
2026-10-03
Completion
2026-11-03
First posted
2024-05-16
Last updated
2025-02-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06415474. Inclusion in this directory is not an endorsement.